CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastomaMasahiro Nishikawa, Takeharu Kunieda, Riko Kitazawa et al.|Cancer Medicine|2021Cited by 26
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastomaMasahiro Nishikawa, Takeharu Kunieda, Akihiro Inoue et al.|Translational Oncology|2021Cited by 26
Met-PET uptake index for total tumor resection: identification of 11C-methionine uptake index as a goal for total tumor resection including infiltrating tumor cells in glioblastomaAkihiro Inoue, Takeharu Kunieda, Takanori Ohnishi et al.|Neurosurgical Review|2020Cited by 20
Tricks and traps of ICG endoscopy for effectively applying endoscopic transsphenoidal surgery to pituitary adenomaAkihiro Inoue, Takeharu Kunieda, Shohei Kohno et al.|Neurosurgical Review|2020Cited by 20
Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsyYawara Nakamura, Takeharu Kunieda, Akihiro Inoue et al.|Acta Neurochirurgica|2022Cited by 17